Cancer of Unknown Primary. Dieser Artikel ist nicht verfügbar.
Sprache: Englisch
Verlag: Springer, 2015
- Hardcover
- Neu

Anbieter: preigu, Osnabrück, Deutschlandpreigu
Verkäufer:in bei AbeBooks seit 5. August 2024
Zustand: Neu
EUR 93,35
Artikelbeschreibung des Verkäufers
Cancer of Unknown Primary | Alwin Krämer (u. a.) | Buch | vi | Englisch | 2015 | Springer | EAN 9783319225807 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Bestandsnummer des Verkäufers 104539221
- Titel
- Cancer of Unknown Primary
- Autor
- Alwin Krämer (u. a.)
- Verlag
- Springer
- Erscheinungsjahr
- 2015
- Zustand
- Neu
- Einband
- Buch
- Sprache
- Englisch
- ISBN-10
- 3319225804
- ISBN-13
- 9783319225807
- Artikelgewicht
- 507 Gramm
- Abmessungen
- 241 x 160 x 16 mm
- Verkäuferkataloge
- Bücher
This book presents an up-to-date and thorough overview of cancer of unknown primary, encompassing topics ranging from epidemiology, tumor biology, and prognostic factors through to the most recent diagnostic and therapeutic advances. All aspects of management are covered, including radiological, nuclear medicine, and pathological diagnosis, site-specific therapies, platinum-based combination chemotherapy, radiotherapy, and novel targeted treatments. Clear guidance is offered on diagnosis of the tissue of origin by means of gene expression and micro-RNA analyses and its therapeutic implications. Detailed directions are also provided on the identification of subsets of patients with a more favorable prognosis, in whom specific treatment offers the chance of long-term survival or even cure. Readers will find Cancer of Unknown Primary to be an ideal source of practically oriented information that will assist in delivery of the best possible care for patients with this challenging diagnosis.
„Inhaltsangabe“ gehört möglicherweise zu einer anderen Auflage dieses Titels.
Von der hinteren Coverseite
This book presents an up-to-date and thorough overview of cancer of unknown primary, encompassing topics ranging from epidemiology, tumor biology, and prognostic factors through to the most recent diagnostic and therapeutic advances. All aspects of management are covered, including radiological, nuclear medicine, and pathological diagnosis, site-specific therapies, platinum-based combination chemotherapy, radiotherapy, and novel targeted treatments. Clear guidance is offered on diagnosis of the tissue of origin by means of gene expression and micro-RNA analyses and its therapeutic implications. Detailed directions are also provided on the identification of subsets of patients with a more favorable prognosis, in whom specific treatment offers the chance of long-term survival or even cure. Readers will find Cancer of Unknown Primary to be an ideal source of practically oriented information that will assist in delivery of the best possible care for patients with this challenging diagnosis.
„Über diesen Titel“ gehört möglicherweise zu einer anderen Auflage dieses Titels.